Edwards Lifesciences (EW) vs Koninklijke Philips N.V. NY Registry Shares (PHG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edwards Lifesciences (EW) has outperformed Koninklijke Philips N.V. NY Registry Shares (PHG) over the past year, gaining 11.8% versus a loss of 14.0%. Over five years, EW leads with a -23.5% price change compared with -45.5% for PHG. Edwards Lifesciences is the larger company by market cap ($48.56 billion vs $23.75 billion), about 2.0 times the size.
On valuation, Koninklijke Philips N.V. NY Registry Shares trades at a lower forward P/E (12.8x vs 24.9x for Edwards Lifesciences). Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.50%, while Edwards Lifesciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | PHG |
|---|---|---|
| Share price | $84.24 | $24.30 |
| Market cap | $48.56B | $23.75B |
| 1-day change | -1.80% | +0.87% |
| YTD return | +0.62% | -10.27% |
| 1-year return | +11.81% | -13.98% |
| 5-year return | -23.52% | -45.48% |
| P/E ratio (TTM) | 50.14 | 18.13 |
| Forward P/E | 24.90 | 12.83 |
| EPS (TTM) | $1.68 | $1.34 |
| Dividend yield | 0.00% | 3.50% |
| Annual dividend | $0.00 | $0.85 |
| Revenue (latest FY) | $6.07B | — |
| Revenue growth (YoY) | +11.55% | — |
| Net income (latest FY) | $1.07B | — |
| Gross margin | 78.01% | — |
| Operating margin | 20.84% | — |
| Net margin | 17.69% | — |
| 52-week high | $96.29 | $33.44 |
| 52-week low | $72.30 | $23.62 |
| Distance from 52-week high | -12.51% | -27.33% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +21.04% | +31.77% |
| Average volume | 3.82M | 994.93K |
| Shares outstanding | 576.40M | 977.43M |
| Employees | 16,000 | 63,670 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical Electronics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 2.0 times larger than Koninklijke Philips N.V. NY Registry Shares by market value ($48.56B vs $23.75B).
- EW has outperformed PHG by 25.8 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (50.1x vs 18.1x trailing P/E).
- Koninklijke Philips N.V. NY Registry Shares offers a meaningfully higher dividend yield (3.50% vs 0.00%).
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Health Care · Industrial Specialties · 16,000 employees
About Koninklijke Philips N.V. NY Registry Shares
PHG stock →Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Health Care · Medical Electronics · 63,670 employees
EW vs PHG FAQ
Which is bigger, Edwards Lifesciences or Koninklijke Philips N.V. NY Registry Shares?
Edwards Lifesciences (EW) is larger, with a market capitalization of $48.56B compared with $23.75B for Koninklijke Philips N.V. NY Registry Shares (PHG).
Which stock has performed better over the past year, EW or PHG?
EW returned +11.81% over the past 12 months, compared with -13.98% for PHG (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or PHG?
PHG has the lower trailing P/E at 18.1, versus 50.1 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or Koninklijke Philips N.V. NY Registry Shares?
Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.50%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and Koninklijke Philips N.V. NY Registry Shares in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Edwards Lifesciences and Medical Electronics for Koninklijke Philips N.V. NY Registry Shares.